<<

Index

A

Ajellomycetaceae, 82

Amphibians, 260

Amphotericin B, 91,94,124,125,154,168-170, 191, 219-221, 262, 274, 341, 350, 351, 360, 362, 363, 365, 367, 370, 373, 375, 376, 380, 383-386

Anamorph, 341, 342

Anthropophilic dermatophytes, 11, 12 Antifungal agents

resistance, in animals

Aspergillus, 384, 385 azole-resistant A.

fumigatus, 385 Candida sp., 383 Cryptococcus sp., 383 Malassezia pachydermatis, 383 mechanisms, 382

systemic (see Systemic antifungal agents) topical antifungals, 381, 382

Aspergillus sp.

A. felis, 339, 345

A. flavus, 348

A. fumigatus, 338, 341, 343, 345, 348

A. fumigatus complex species, 342

A. lentulus, 339, 341

A. niger, 348

A. parafelis, 339

A. thermomutatus, 339, 346

A. viridinutans, 338, 339, 349, 351

A. wyomingensis, 339

Azoles

chemical structures, 369, 370

description, 369

imidazoles

ketoconazole, 370, 371

parconazole, 371

triazoles

fluconazole, 371, 372 isavuconazole, 377 itraconazole, 372-374 posaconazole, 375-377 voriconazole, 374, 375

B

Black yeast, 237, 238, 240, 244 Blastomycosis

Blastomyces, 159, 160

clinical signs, 162-164

diagnosis, 165-167

treatment, 168-170

C

Calmodulin, 340

Caspofungin, 351

Chiroptera, 304

Chronic obstructive pulmonary disease (COPD), 137

Chytridiomycosis

B. dendrobatidis, 311-313

B. salamandrivorans, 313-314 causative agents, 310 diagnosis, 322, 323 outbreaks, 312-314 treatment, 323-327

Chytridiomycota, 310

Chytrids, 310-311 Clotrimazole, 350, 381, 385

Coccidioides

C. immitis, 82, 83, 86, 89, 97

C. posadasii, 82, 83, 86, 89, 96, 98 distribution and prevalence, 90 life cycle, 83, 84

© Springer International Publishing AG, part of Springer Nature 2018

403

S. Seyedmousavi et al. (eds.), Emerging and Epizootic Fungal Infections in Animals, https://doi.org/10.1007/978-3-319-72093-7

Coccidioidin, 87, 99

Coccidioidomycosis, 81-102, 363, 364, 367, 370, 371, 374

Cold-blooded vertebrates

amphibians, 260

reptiles, 260

zebra fish (Danio rerio), 260

Common bottlenose dolphin, 187

Cryptococcosis

clinical manifestations, 250

diagnosis of, 273

epidemiological studies, 251, 252

etiology and taxonomy, 251-253 histology, 271 prevention, 275 treatment, 274-275 zoonotic potential, 269

Cryptococcus gattii, 250, 251, 253-256, 258

D

Dermatophytes

anthropophilic species, 63

geophilic species, 37

morphology and nutritional tests, 34 species identification, 34 zoonotic transmission risks, 32

E

Echinocandins, 377-379, 385, 386

Enilconazole, 382, 385

Eurotiomycetes, 82

Exophiala cancerae, 237, 240-245

F

Feline aspergillosis

classification, 338

clinical presentations, 346-347 diagnosis, 347-350

epidemiology, 343

pathogenesis and pathology, 343-346 treatment and prognosis, 350-352

Fluconazole, 371, 372, 374, 383

Flucytosine, 379, 380

Fonsecaea brasiliensis, 238, 240-242, 245

G

Geophilic dermatophytes, 11

Gomori methenamine silver (GMS) stain, 188

Griseofulvin, 380, 381

Grocott's methenamine silver (GMS),

167, 344

H

Haematoxylin and eosin (H&E) staining, 188, 323

Hematopancreatic parso-like virus (HPV), 237 Hematophagous flies, 120

Hibernation, 290, 297, 299

Histofarcin skin test, 124

Histoplasma capsulatum

var.

capsulatum, 116, 117, 119-121, 125 var. duboisii, 116, 121

var. farciminosum, 116, 117, 119, 120, 122-124

Histoplasmosis

causative agents, 116-117 control, 124-125 diagnosis, 123, 124 epidemiology, 117-120 public health, 125

I

Imidazoles

ketoconazole, 370, 371

parconazole, 371

Isavuconazole, 377

Itraconazole, 350, 351, 372-376, 383-385

K

Ketoconazole, 370-372

L

Lacazia loboi, 131, 178-182, 189

Lethargic crab disease (LCD), 8, 233-246

Lobomycosis, 178

M

Marine mammals, 267

Marsupials, 261-262

Miconazole, 324

Microsatellite markers, 43

Microsporum canis, 47, 49-51

Minimal inhibitory concentrations (MIC), 320

Mixophyes fasciolatus, 315

Multilocus sequence typing (MLST), 117

N

Natamycin, 381

Nonhuman primates, 267

Nystatin, 367, 368

P

Paracoccidioides

classification, 140 ecology, 133

P. brasiliensis, 130, 179

P. lutzii, 130, 131

Paracoccidioides brasiliensis var. ceti clinical signs and lesions, 185-188 host response and pathogenesis, 184-185 laboratory diagnosis, 190 pathological findings, 188 taxonomy, 179-184 treatment, 191

Paracoccidioidomycosis causative agents, 130-131 clinical approaches, 130 diagnosis, 139-140 ecology, 133 public health, 140-141

Parconazole, 371

Polyenes amphotericin B, 362, 367 nystatin, 367, 368

Polymyxin E, 324

Posaconazole, 191, 220, 274, 350-352, 365, 369-371, 375-377, 383, 385

Pseudogymnoascus, see White-nose syndrome (WNS)

Pseudomycetomas, 345

R

Reptiles, 260

Resistance, antifungal mechanisms, 382, 383

Rodents, 265, 266

Ruminants, 265-266

S

Sapronoses, 6, 24

Single-nucleotide polymorphisms (SNPs), 312, 345

Sinonasal aspergillosis (SNA), 338, 349, 351

Sino-orbital aspergillosis (SOA), 338, 346 Sotalia guianensis, 178

Spherules, 83, 91, 95, 101

Splendore-Hoeppli phenomenon, 215

Sporothrix sp.

etiology, 200

S. brasiliensis, 6, 7, 9, 12, 22, 23, 201-205, 207-212, 214, 216, 217, 219-222

S.

globosa, 203-205, 207, 213, 214, 217, 219

S. schenckii, 6, 9, 200, 202, 203, 205, 207, 209-211, 213, 214, 216, 217, 219, 222

Sulfadimethoxine, 191 Sulfamethoxypyridazine, 191

Synanthropic rodents, 267-268

Systemic antifungal agents

echinocandins, 377-379

griseofulvin, 380, 381

polyenes (see Polyenes)

T

Terbinafine, 191, 219, 220, 274, 351, 360, 363, 368-369, 386

Thiabendazole, 382

Transmissible fungal infections, 18-24

Triazoles

fluconazole, 371, 372

itraconazole, 372-374

posaconazole, 375-377

voriconazole, 374, 375

Trichophyton sp.

T. benhamiae, 56-58

T. equinum, 55, 56

T. erinacei, 58-60

T. verrucosum, 53-55

V

Virulence factors, 22, 34-35, 89, 171, 240, 256-259, 299, 345

Voriconazole, 154, 168, 220, 274, 324, 351, 364, 367, 369-371, 374-375, 383-385

W

Warm-blooded vertebrates birds, 261 carnivores, 265 cats, 263-264 dogs, 262-263 equids, 266-267 marine mammals, 267 marsupials, 261-262

Warm-blooded vertebrates (cont.) nonhuman primates, 267 rodents, 265, 266 ruminants, 265-266

White-nose syndrome (WNS) causative agent, 300-301 clinical signs, 297 geographic distribution and host range, 302-303

pathogenesis, 298-299

X

Xenarthran species, 134

Z

Zebra fish (Danio rerio), 260

Zoonosis, 21, 22, 200, 208, 211, 221, 222

Zoonotic transmission, 200, 208, 211

Zoophilic dermatophytes, 11, 32, 38-56, 63-65 Zoosporangium, 310

<< |
Source: Seyedmousavi S. et al. (eds). Emerging and Epizootic Fungal Infections in Animals. Springer International Publishing,2018. - 406 p. 2018

More on the topic Index: